NasdaqGS - Delayed Quote • USD
AngioDynamics, Inc. (ANGO)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 3 | 4 |
| Avg. Estimate | -0.16 | -0.17 | -0.52 | -0.49 |
| Low Estimate | -0.21 | -0.21 | -0.57 | -0.68 |
| High Estimate | -0.12 | -0.1 | -0.44 | -0.27 |
| Year Ago EPS | 0.02 | -0.12 | -0.06 | -0.52 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 70.89M | 68.82M | 287.31M | 287.25M |
| Low Estimate | 70.5M | 68.29M | 270.8M | 286M |
| High Estimate | 71.2M | 69.6M | 304M | 290M |
| Year Ago Sales | 91.07M | -- | 338.75M | 287.31M |
| Sales Growth (year/est) | -22.20% | -- | -15.20% | -0.00% |
Earnings History
| CURRENCY IN USD | 5/31/2023 | 8/31/2023 | 11/30/2023 | 2/29/2024 |
|---|---|---|---|---|
| EPS Est. | 0.02 | -0.13 | -0.07 | -0.13 |
| EPS Actual | 0.02 | -0.12 | -0.05 | -0.16 |
| Difference | 0 | 0.01 | 0.02 | -0.03 |
| Surprise % | 0.00% | 7.70% | 28.60% | -23.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.16 | -0.17 | -0.52 | -0.49 |
| 7 Days Ago | -0.16 | -0.17 | -0.52 | -0.49 |
| 30 Days Ago | -0.12 | -0.16 | -0.43 | -0.37 |
| 60 Days Ago | -0.12 | -0.16 | -0.43 | -0.37 |
| 90 Days Ago | -0.09 | -0.13 | -0.39 | -0.25 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ANGO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -900.00% | -- | -- | 5.40% |
| Next Qtr. | -41.70% | -- | -- | 10.90% |
| Current Year | -766.70% | -- | -- | 4.50% |
| Next Year | 5.80% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 10.94% |
| Past 5 Years (per annum) | -42.23% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | Oppenheimer: Perform to Outperform | 4/5/2024 |
| Maintains | Raymond James: Outperform to Outperform | 1/9/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/8/2024 |
| Maintains | Raymond James: Outperform to Outperform | 10/6/2023 |
| Maintains | Canaccord Genuity: Buy to Buy | 10/5/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 10/5/2023 |
Related Tickers
ANIK Anika Therapeutics, Inc.
25.57
-0.04%
HBIO Harvard Bioscience, Inc.
3.6200
+1.69%
ATRC AtriCure, Inc.
23.17
+2.48%
ICUI ICU Medical, Inc.
94.84
+0.33%
MMSI Merit Medical Systems, Inc.
73.78
+0.55%
TFX Teleflex Incorporated
206.71
0.00%
UTMD Utah Medical Products, Inc.
65.92
-0.56%
OSUR OraSure Technologies, Inc.
5.32
+1.14%
STXS Stereotaxis, Inc.
2.3000
-2.13%
WRBY Warby Parker Inc.
12.92
+1.33%